Atlas Trials

Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck

Clinical trial NCT00003182 · UNKNOWN

Trial details

NCT number
NCT00003182
Sponsor
Hope Cancer Institute, Inc.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
1997-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.